Otrivin Nasal Spray

Otrivin is a nasal decongestant spray developed to provide relief from nasal congestion caused by colds, allergies, or sinusitis. Manufactured in multiple countries, Otrivin is produced by Haleon, a UK-based consumer healthcare company formed in 2022. Prior to this, the brand was owned by GlaxoSmithKline, a British multinational pharmaceutical company. Otrivin's active ingredient, xylometazoline hydrochloride, works by constricting nasal blood vessels, thereby reducing swelling and allowing easier breathing. The product is available in various forms, including nasal sprays and drops, and is widely used for its efficacy in alleviating nasal congestion symptoms.